每經AI快訊，靈(ling)康(kang)藥業（SH 603669，收盤價：5.75元）11月14日(ri)晚間(jian)發(fa)布公(gong)(gong)(gong)告稱，截(jie)至公(gong)(gong)(gong)告披露日(ri)公(gong)(gong)(gong)司(si)控股股東靈(ling)康(kang)控股集團有限(xian)公(gong)(gong)(gong)司(si)直(zhi)接(jie)持(chi)有公(gong)(gong)(gong)司(si)股份約3.4億股無限(xian)售(shou)流通股股票(piao)，占(zhan)公(gong)(gong)(gong)司(si)總(zong)股本的(de)47.09%，靈(ling)康(kang)控股累計(ji)質押公(gong)(gong)(gong)司(si)股票(piao)數量約為1.04億股，占(zhan)其持(chi)有公(gong)(gong)(gong)司(si)股份總(zong)數的(de)30.52%，占(zhan)公(gong)(gong)(gong)司(si)總(zong)股本的(de)14.37%。

2024年1至(zhi)12月份，靈(ling)康藥(yao)業的營業收入構成(cheng)為：醫藥(yao)占(zhan)比84.62%，醫藥(yao)流通(tong)占(zhan)比12.19%，其他業務占(zhan)比2.7%，醫院銷售及(ji)配送(song)占(zhan)比0.48%。

截至發(fa)稿，靈康藥業市值為41億(yi)元。

每經(jing)頭條（nbdtoutiao）——

（記者 曾健輝）

免責聲明(ming)：本(ben)文內(nei)容(rong)與數據(ju)僅供參考，不(bu)構成投資(zi)建議，使(shi)用(yong)前請核實。據(ju)此操作，風險自擔。